C
Clal, through its venture capital activities, focuses on identifying and supporting promising innovative ventures. Its Clal Biotechnology Industries (CBI) arm specializes in the life sciences sector, including biotech, pharma, diagnostics, and medical devices, investing in companies from seed to maturity. Additionally, ClalTech, a division of Clal Industries, invests in Israeli technology startups, often in growth rounds, with a broad focus that includes software and internet platforms.
50% of their portfolio is in AI. They made 2 investments in the last 12 months. Their most common stage is series-c (100% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series C
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Classiq | Series C | $110M | May 2025 |
 Classiq Technologies LTD | Series C | $110M | May 2025 |
Top Co-Investors
Norwest Venture Partners2 shared
NightDragon2 shared
Hamilton Lane2 shared
NEVA SGR2 shared
Phoenix Capital Ventures2 shared
Team82 shared
First In2 shared
Wing2 shared
HSBC2 shared
Samsung Next2 shared
QBeat1 shared
Last updated: 28 April 2026